Mar. 21 at 5:09 PM
$GALT Guys, stop complaining with management. Did you give Joel a credit for finding Dr. Henry Brem, M.D.? The answer is NO.
As long as the drug is not approved yet, shorts will be all over this stock. The only way you can make money is that if the stock meets your target price such as
$7 last year, you have to sell to make money. If you decide to hold and sell at BO, then you have to take that risk and hold the stock longer. Even when the drug is approved by FDA, the stock may still crash with small biotech stocks. We call it as ‘sell the news’. I held AUPH stock through FDA APPROVAL. It was approved on Friday night and the following Monday, the stock price just went up from
$16 to
$20+ which was nothing. But if the drug is not approved, it would probably cut 80%.
I don’t see Richard will try to go it alone after the drug is approved. So, I will continue to stick with best science and follow big money. Will sell at BO.
Day to day stock price fluctuation is not important. GLTA!
